School of Medicine
Showing 11-20 of 51 Results
Instructor, Medicine - Pulmonary & Critical Care Medicine
Current Research and Scholarly Interests I am currently working to develop an orthotopic tracheal transplant model for Aspergillus infection and colonization. I am also involved in developing a device to detect pathogen-specific signatures in exhaled breath samples.
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly Interests Our research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms
Kristina Kudelko, MD
Clinical Assistant Professor, Medicine - Pulmonary & Critical Care Medicine
Current Research and Scholarly Interests Drugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, acute kidney injury in pulmonary arterial hypertension
Ware Kuschner, M.D.
Professor of Medicine (Pulmonary and Critical Care Medicine) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests Occupational and environmental lung disease; Pulmonary and systemic responses to toxicant inhalation; Indoor and outdoor air pollution health effects;
Joseph Levitt, MD, MS
Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).